These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6314208)

  • 1. Morphine exacerbates anaphylactic shock in mice by stimulating central opiate receptors.
    Amir S
    Neurosci Lett; 1983 Sep; 40(2):169-74. PubMed ID: 6314208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone improves, and morphine exacerbates, experimental shock induced by release of endogenous histamine by compound 48/80.
    Amir S
    Brain Res; 1984 Apr; 297(1):187-90. PubMed ID: 6722534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate antagonists reverse the hypoactivity associated with systemic anaphylaxis in mice.
    Amir S
    Pharmacol Biochem Behav; 1984 Mar; 20(3):483-5. PubMed ID: 6709679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proanaphylactic action of morphine is mediated through a central cholinergic mechanism.
    Amir S
    Eur J Pharmacol; 1983 Nov; 95(1-2):117-9. PubMed ID: 6667710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endorphins in endotoxin-induced hyperglycaemia in mice.
    Amir S; Harel M
    Neuropharmacology; 1983 Sep; 22(9):1117-9. PubMed ID: 6633822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat.
    Bardo MT; Bhatnagar RK; Gebhart GF
    Brain Res; 1983 Dec; 289(1-2):223-34. PubMed ID: 6318895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone improves survival rate and cardiovascular function in canine hemorrhagic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):625-8. PubMed ID: 6278127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endorphins in endotoxin-induced hyperglycemia in mice.
    Amir S; Harel M
    Arch Toxicol Suppl; 1983; 6():261-5. PubMed ID: 6578730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent and control of shock affects naltrexone sensitivity of stress-induced analgesia and reactivity to morphine.
    Hyson RL; Ashcraft LJ; Drugan RC; Grau JW; Maier SF
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1019-25. PubMed ID: 6294682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.
    Tempel A; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):439-44. PubMed ID: 2982011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactic shock: catecholamine actions in the responses to opioid antagonists.
    Amir S
    Prog Clin Biol Res; 1988; 264():265-74. PubMed ID: 2454493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of morphine-induced behavioral suppression by opiate receptor alkylators.
    Messing RB; Portoghese PS; Takemori AE; Sparber SB
    Pharmacol Biochem Behav; 1982 Apr; 16(4):621-6. PubMed ID: 6280206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraseptally injected opiate agents: effects on morphine-induced behaviour of cats.
    Megens AA; Cools AR
    Pharmacol Biochem Behav; 1982 Aug; 17(2):297-304. PubMed ID: 6291068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol-opioid interaction in mice.
    Tamborska E; Kotlińska J; Langwiński R
    Pol J Pharmacol Pharm; 1984; 36(4):337-44. PubMed ID: 6098896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of an opiate response to nitrous oxide in mice resistant to the activity-stimulating effects of morphine.
    Hynes MD; Berkowitz BA
    J Pharmacol Exp Ther; 1982 Mar; 220(3):499-503. PubMed ID: 6278126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.